OPTN/SRTR 2015 Annual Data Report: Economics

Abstract

While the costs to Medicare of solid organ transplants are varied and considerable, the total Medicare expenditure of $4.4 billion for solid organ transplant recipients in 2014 remained less than 1% of all Medicare expenditures. For patients covered by Medicare, the ratio of pre- to posttransplant cost of care varied widely by organ and within some organ categories by patient characteristics. This chapter reports pretransplant costs for all solid organ candidates covered by Medicare to allow investigators to further explore the relative cost of transplant compared with alternative management.

Kidney

Medicare coverage for some or all of the care of kidney transplant recipients in 2014 varied from 58.0% for children to 98.2% for recipients aged 65 years or older (Figure Econ 1). From transplant through the first year posttransplant, the average reimbursement for kidney recipients with primary Medicare coverage in 2008-2013 was $64 thousand for Part A and $19 thousand for Part B (Table Econ 2). The cost of care in the second year was approximately one-third of first-year costs, at $14 thousand for Part A and $10 thousand for Part B, totaling $24 thousand in 2008-2012 (Table Econ 3). This compares with Medicare expenditure of $47 thousand during the year preceding transplant, 194% of second-year posttransplant costs (Table Econ 1). Kidney transplant recipients experienced the least frequent rehospitalization rates among solid organ recipients, with 151 rehospitalizations per person-year at risk during the first posttransplant year and 71 during the second (Figure Econ 2). Transplant complications were the most common reason for readmission during the first posttransplant year and infections during the second. The total Part A and Part B Medicare expenditure for kidney transplant recipients was $2.5 billion in 2012 for the care of 111,531 patients; this increased to $2.6 billion in 2014 for the care of 116,939 patients (Table Econ 4). Kidney transplant recipients accounted for 65.8% of all solid organ recipients covered by Medicare and for 59.7% of all Medicare expenditures for solid organ transplant recipients in 2014. Average Medicare expenditure in 2014 for 116,939 kidney recipients was $24,879, the least expensive per patient of all solid organ transplants. The proportion of expenditure declined to 59.9% in 2013, from 60.2% in 2012 and 60.4% in 2011. The continuing decline has been due to relatively increasing coverage of recipients of other organs.

Pancreas

Medicare coverage for some or all of the care of pancreas transplant recipients in 2014 varied from 1.7% for children to 87.5% for recipients aged 65 years or older (Figure Econ 3). From transplant through the first year posttransplant, the average reimbursement for pancreas recipients with primary Medicare coverage in 2008-2013 was $95 thousand for Part A and $24 thousand for Part B (Table Econ 7). Pancreas recipients were rehospitalized more frequently than kidney recipients: 254 compared with 151 rehospitalizations per 100 years at risk in the first year posttransplant (Figure Econ 7, Figure Econ 2). Rehospitalizations for cardiovascular complications were somewhat less common for pancreas recipients than for kidney recipients, 11 vs. 13. However, other reasons for hospitalization were much more common among pancreas recipients. Pancreas recipients were more expensive than kidney recipients during both the first and second years posttransplant, totaling $120 thousand in the first year, compared with $83 thousand, and $33 thousand in the second year, compared with $24 thousand (Table Econ 7, Table Econ 2, Table Econ 8, Table Econ 3). This compares with Medicare expenditure of $49 thousand during the year preceding pancreas transplant, 149% of second-year posttransplant costs (Table Econ 6). The total Medicare expenditure for pancreas recipients in 2014 was $232 million. The average Medicare expenditure in 2014 for 8305 pancreas recipients was $30,056, 121% of the average cost of kidney recipients and third least expensive per patient of all solid organ transplants (Table Econ 9). Pancreas recipients accounted for 4.7% of all solid organ recipients covered by Medicare and 5.3% of all Medicare expenditures for solid organ transplant recipients in 2014.

Liver

Medicare coverage for some or all of the care of liver transplant recipients in 2014 varied from 1.5% for children to 90.3% for recipients aged 65 years or older (Figure Econ 5). The average reimbursement for liver recipients with primary Medicare coverage from transplant through the first year posttransplant was $162 thousand for Part A and $26 thousand for Part B (Table Econ 12), totaling $188 thousand. This is more than twice the average Medicare expenditure for kidney transplant recipients, at $83 thousand (Table Econ 2). However, the long-term costs of care, represented by costs in the second year posttransplant, were similar for liver ($29 thousand) and kidney ($24 thousand) recipients (Table Econ 13, Table Econ 3, respectively). This compares with Medicare expenditure of $50 thousand during the year preceding liver transplant, 174% of second-year posttransplant costs (Table Econ 11). The total Medicare expenditure for liver recipients in 2014 was $739 million (Table Econ 14). Average Medicare expenditure in 2014 for 30,641 liver recipients was $25,992, 104% of the average cost for kidney recipients and second least expensive per patient of all solid organ transplants (Table Econ 15). Liver recipients accounted for 17.2% of all solid organ recipients covered by Medicare and 16.8% of all Medicare expenditures for solid organ transplant recipients in 2014.

Intestine

Medicare coverage for some or all of the care of intestine transplant recipients in 2014 varied from 0.7% for children to 84.6% for recipients aged 65 years or older (Figure Econ 7). Intestine transplant was the most expensive solid organ transplant reimbursed by Medicare in 2014, with average first-year costs of $349 thousand for Part A and $44 thousand for Part B (Table Econ 17), totaling $393 thousand. Intestine recipients were rehospitalized frequently, with 709 rehospitalizations per 100 years at risk in the first posttransplant year and 355 in the second (Figure Econ 8). Medicare expenditure during the second year posttransplant averaged $108 thousand compared with $130 thousand during the year preceding intestine transplant, 120% of second-year posttransplant costs (Table Econ 18, Table Econ 16, respectively). Because of the small number of procedures, the total Medicare expenditure for intestine transplant recipients in 2014 was $13 million (Table Econ 19), less than 1% of all Medicare expenditures for solid organ transplant recipients. However, at the patient level, average expenditure for 270 intestine recipients in 2014 was $55,979, 225% of the average cost of kidney recipients and the most expensive per patient of all solid organ transplants (Table Econ 20).

Heart

Medicare coverage for some or all of the care of heart transplant recipients in 2014 varied from 0.1% for children to 91.4% for recipients aged 65 years or older (Figure Econ 9). The average Medicare reimbursement from transplant through the first year posttransplant was $270 thousand for Part A and $35 thousand for Part B (Table Econ 22), totaling $305 thousand, the second-highest average total costs, below intestine transplant. Rehospitalization rates following heart transplant were similar to rates following kidney transplant, with 169 rehospitalizations per 100 years at risk in the first posttransplant year and 83 in the second (Figure Econ 10). However, average second-year Medicare costs after heart transplant, at $36 thousand, were 149% of second-year costs following kidney transplant (Table Econ 23). This compares with Medicare expenditure of $112 thousand during the year preceding heart transplant, 312% of second-year posttransplant costs (Table Econ 21). The total Medicare expenditure for heart recipients in 2014 was $485 million (Table Econ 24). Average Medicare expenditure in 2014 for 14,130 heart recipients was $37,174, 149% of the average cost of kidney recipients and the third most expensive per patient of all solid organ transplants (Table Econ 25). Heart recipients accounted for 8.0% of all solid organ recipients covered by Medicare and 11.0% of all Medicare expenditures for solid organ transplant recipients in 2014.

Lung

Medicare coverage for some or all of the care of lung transplant recipients in 2014 varied from 0.0% for children to 93.3% for recipients aged 65 years or older (Figure Econ 11). The average Medicare reimbursement from transplant through the first year posttransplant was $212 thousand for Part A and $28 thousand for Part B (Table Econ 27), totaling $240 thousand, the third-highest average total costs, below intestine and heart transplants. Rehospitalization rates following lung transplant were similar to rates following pancreas transplant, with 259 rehospitalizations per 100 years at risk in the first posttransplant year and 148 in the second (Figure Econ 12). However, average second-year Medicare costs after lung transplant, at $52 thousand, were 158% of second-year costs following pancreas transplant (Table Econ 28). This compares with Medicare expenditure of $32 thousand during the year preceding lung transplant, 62% of second-year posttransplant costs (Table Econ 26). The total Medicare expenditure for lung recipients in 2014 was $308 million (Table Econ 29). The average Medicare expenditure in 2014 for 7375 lung recipients was $47,615, 191% of the average cost of kidney recipients and the second most expensive per patient of all solid organ transplants (Table Econ 30). Lung recipients accounted for 4.2% of all solid organ recipients covered by Medicare and 7.0% of all Medicare expenditures for solid organ transplant recipients in 2014.

Pretransplant Costs

In this Annual Data Report, SRTR continues to release new data suitable for use in cost-effectiveness modeling in solid organ transplantation. The release of pretransplant data for lung last year has been expanded to include all organs this year. Future Annual Data Reports will continue to expand upon the depth and breadth of economic data reported to support inquiries of researchers, policy makers, and the general public.

Pretransplant costs of care for Medicare-covered transplant candidates who underwent transplant were summed across 30, 90, and 365 days before transplant. These are included for each organ for all recipients and stratified by age, sex, race/ethnicity, and organ-specific primary diagnosis. The cost of the inpatient hospitalization for transplant was included in the first-year posttransplant hospitalization costs, not in pretransplant costs. Including pretransplant costs facilitates detailed cost analysis. Pretransplant cost information may allow analysis of alternative treatment strategies, such as estimation of the adjusted cost of alternative therapeutic options to transplant.

Costs during the pretransplant year compared favorably to, i.e., were greater than, long-term posttransplant costs (represented by costs during the second posttransplant year) in most cases. This has long been understood with regard to kidney transplant, and is a fundamental pattern behind the argument that kidney transplant is cost saving. This pattern occurred for all other organs except for lung, and for many lung subsets. This pattern does not guarantee that all of these transplants are cost saving; cost savings requires relatively long survival at high costs without transplant, as with dialysis. However, cost savings from transplant are possible and cost effectiveness is highly likely in selected cases other than kidney transplant.

The reported pretransplant costs create the opportunity to consider the relative costs and, with assumptions concerning pretransplant and posttransplant survival, the cost-effectiveness of solid organ transplant modalities compared with alternative treatments. Non-renal solid organ transplants may be cost-saving for certain groups of patients. Cost-effectiveness of many, and perhaps most, solid organ transplants is likely.

Figure List

Kidney

Figure Econ 1. Medicare coverage among kidney transplant recipients, 2008-2014
Figure Econ 2. Rehospitalization rates among kidney transplant recipients in years 1 and 2 posttransplant

Pancreas

Figure Econ 3. Medicare coverage among pancreas transplant recipients, 2008-2014
Figure Econ 4. Rehospitalization rates among pancreas transplant recipients in years 1 and 2 posttransplant

Liver

Figure Econ 5. Medicare coverage among liver transplant recipients, 2008-2014
Figure Econ 6. Rehospitalization rates among liver transplant recipients in years 1 and 2 posttransplant

Intestine

Figure Econ 7. Medicare coverage among intestine transplant recipients, 2008-2014
Figure Econ 8. Rehospitalization rates among intestine transplant recipients in years 1 and 2 posttransplant

Heart

Figure Econ 9. Medicare coverage among heart transplant recipients, 2008-2014
Figure Econ 10. Rehospitalization rates among heart transplant recipients in years 1 and 2 posttransplant

Lung

Figure Econ 11. Medicare coverage among lung transplant recipients, 2008-2014
Figure Econ 12. Rehospitalization rates among lung transplant recipients in years 1 and 2 posttransplant

Table List

Kidney

Table Econ 1. Per person per year Medicare costs of kidney transplant recipients during the year prior to transplant
Table Econ 2. Total and per person per year Medicare costs of kidney transplant recipients in year 1 posttransplant
Table Econ 3. Total and per person per year Medicare costs of kidney transplant recipients in year 2 posttransplant
Table Econ 4. Total calendar-year Medicare costs of kidney transplant recipients, 2011, 2012, and 2013
Table Econ 5. Per person per year calendar-year Medicare costs of kidney transplant recipients, 2012, 2013, and 2014

Pancreas

Table Econ 6. Per person per year Medicare costs of pancreas transplant recipients during the year prior to transplant
Table Econ 7. Total and per person per year Medicare costs of pancreas transplant recipients in year 1 posttransplant
Table Econ 8. Total and per person per year Medicare costs of pancreas transplant recipients in year 2 posttransplant
Table Econ 9. Total calendar-year Medicare costs of pancreas transplant recipients, 2012, 2013, and 2014
Table Econ 10. Per person per year calendar-year Medicare costs of pancreas transplant recipients, 2012, 2013, and 2014

Liver

Table Econ 11. Per person per year Medicare costs of liver transplant recipients during the year prior to transplant
Table Econ 12. Total and per person per year Medicare costs of liver transplant recipients in year 1 posttransplant
Table Econ 13. Total and per person per year Medicare costs of liver transplant recipients in year 2 posttransplant
Table Econ 14. Total calendar-year Medicare costs of liver transplant recipients, 2012, 2013, and 2014
Table Econ 15. Per person per year calendar-year Medicare costs of liver transplant recipients, 2012, 2013, and 2014

Intestine

Table Econ 16. Per person per year Medicare costs of intestinal transplant recipients during the year prior to transplant
Table Econ 17. Total and per person per year Medicare costs of intestine transplant recipients in year 1 posttransplant
Table Econ 18. Total and per person per year Medicare costs of intestine transplant recipients in year 2 posttransplant
Table Econ 19. Total calendar-year Medicare costs of intestine transplant recipients, 2012, 2013, and 2014
Table Econ 20. Per person per year calendar-year Medicare costs of intestine transplant recipients, 2012, 2013, and 2014

Heart

Table Econ 21. Per person per year Medicare costs of heart transplant recipients during the year prior to transplant
Table Econ 22. Total and per person per year Medicare costs among heart transplant recipients in year 1 posttransplant
Table Econ 23. Total and per person per year Medicare costs among heart transplant recipients in year 2 posttransplant
Table Econ 24. Total calendar-year Medicare costs of heart transplant recipients, 2012, 2013, and 2014
Table Econ 25. Per person per year calendar-year Medicare costs for heart transplant recipients, 2012, 2013, and 2014

Lung

Table Econ 26. Per person per year Medicare costs of lung transplant recipients during the year prior to transplant
Table Econ 27. Total and per person per year Medicare costs of lung transplant recipients in year 1 posttransplant
Table Econ 28. Total and per person per year Medicare costs of lung transplant recipients in year 2 posttransplant
Table Econ 29. Total calendar-year Medicare costs of lung transplant recipients, 2012, 2013, and 2014
Table Econ 30. Per person per year calendar-year Medicare costs of lung transplant recipients, 2012, 2013, and 2014

Table Econ 1 Per person per year Medicare costs of kidney transplant recipients during the year prior to transplant
Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CKD, cystic kidney disease; GN, glomerulonephritis.

Subgroup	Patients, N	Pre-tx, 365 days	Pre-tx,90 days	Pre-tx, 30 days
All recipients	47,075	46,636	11,120	2861
Age: 0-11	527	59,886	15,290	3555
Age: 12-17	632	47,512	12,238	3216
Age: 18-34	5775	48,783	11,846	3051
Age: 35-49	12,571	47,806	11,373	2908
Age: 50-64	17,445	46,416	11,073	2872
Age: ≥65	10,125	43,595	10,185	2616
Sex: Male	28,652	46,778	11,119	2840
Sex: Female	18,423	46,415	11,122	2893
Race/ethnicity: White	21,836	44,368	10,776	2832
Race/ethnicity: Black	14,524	50,013	11,618	2953
Race/ethnicity: Hispanic	7471	47,780	11,357	2897
Race/ethnicity: Asian	2551	43,681	10,586	2522
Race/ethnicity: Other/unknown	693	45,939	10,939	2713
Diagnosis: Diabetes	14,347	50,408	11,716	3029
Diagnosis: Hypertension	12,134	45,029	10,410	2627
Diagnosis: GN	7739	42,550	10,250	2605
Diagnosis: CKD	4820	41,984	10,125	2520
Diagnosis: Other	8035	49,102	12,569	3365

Table Econ 2 Total and per person per year Medicare costs of kidney transplant recipients in year 1 posttransplant
Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after a transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CKD, cystic kidney disease; GN, glomerulonephritis.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	57,296	3,484,192,029	1,048,212,163	63,660	19,152
Age: 0-11	660	58,997,411	11,958,747	91,708	18,589
Age: 12-17	812	56,481,520	13,790,716	71,609	17,484
Age: 18-34	7130	406,357,301	131,661,200	58,791	19,048
Age: 35-49	15,385	888,572,780	284,927,119	59,958	19,226
Age: 50-64	21,194	1,309,704,558	382,679,894	64,908	18,965
Age: ≥65	12,115	764,078,458	223,194,486	67,087	19,597
Sex: Male	34,966	2,116,367,616	635,778,580	63,359	19,034
Sex: Female	22,330	1,367,824,413	412,433,583	64,131	19,337
Race/ethnicity: White	26,733	1,626,260,803	476,302,287	63,669	18,648
Race/ethnicity: Black	17,594	1,125,897,859	337,115,235	67,367	20,171
Race/ethnicity: Hispanic	9008	511,093,077	169,493,394	58,890	19,530
Race/ethnicity: Asian	3113	174,091,775	51,852,929	58,291	17,362
Race/ethnicity: Other/unknown	848	46,848,515	13,448,318	57,783	16,587
Diagnosis: Diabetes	17,245	1,139,303,416	345,841,965	69,766	21,178
Diagnosis: Hypertension	14,855	850,066,778	267,561,037	60,003	18,886
Diagnosis: GN	9548	507,132,035	159,891,737	55,063	17,360
Diagnosis: CKD	5850	322,063,252	96,417,629	56,888	17,031
Diagnosis: Other	9798	665,626,547	178,499,795	71,096	19,066

Table Econ 3 Total and per person per year Medicare costs of kidney transplant recipients in year 2 posttransplant
Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 posttransplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CKD, cystic kidney disease; GN, glomerulonephritis.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	43,220	597,883,719	418,866,214	14,152	9915
Age: 0-11	520	9,670,633	4,583,459	18,768	8895
Age: 12-17	650	15,407,716	5,786,593	24,319	9133
Age: 18-34	5574	71,282,770	53,142,000	13,098	9764
Age: 35-49	11,826	140,668,755	114,577,724	12,138	9886
Age: 50-64	15,720	225,457,163	151,029,443	14,676	9831
Age: ≥65	8930	135,396,683	89,746,995	15,557	10,312
Sex: Male	26,241	349,123,237	248,594,305	13,622	9700
Sex: Female	16,979	248,760,483	170,271,909	14,970	10,247
Race/ethnicity: White	20,351	282,017,400	192,606,544	14,155	9667
Race/ethnicity: Black	13,151	193,866,880	134,873,024	15,194	10,571
Race/ethnicity: Hispanic	6781	89,192,718	67,601,499	13,364	10,129
Race/ethnicity: Asian	2296	23,527,158	19,154,625	10,413	8477
Race/ethnicity: Other/unknown	641	9,279,563	4,630,522	14,742	7356
Diagnosis: Diabetes	12,760	224,223,861	142,504,414	18,011	11,447
Diagnosis: Hypertension	11,294	143,111,604	108,077,033	13,007	9823
Diagnosis: GN	7294	77,895,983	61,957,098	10,914	8681
Diagnosis: CKD	4432	50,032,926	37,078,673	11,465	8497
Diagnosis: Other	7440	102,619,346	69,248,997	14,072	9496

Table Econ 4 Total calendar-year Medicare costs of kidney transplant recipients, 2011, 2012, and 2013
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units. Values for cells with 9 or fewer recipients are suppressed. CKD, cystic kidney disease; GN, glomerulonephritis.

Subgroup	2012 Patients, N	2012 Total $, Part A	2012 Total $, Part B	2013 Patients, N	2013 Total $, Part A	2013 Total $, Part B	2014 Patients, N	2014 Total $, Part A	2014 Total $, Part B
All recipients	111,531	1,671,842,952	812,288,686	114,343	1,733,740,116	784,148,143	116,939	1,825,531,010	805,538,931
Age: 0-11	935	20,225,143	5,660,231	977	18,159,818	4,803,077	947	19,745,526	4,468,450
Age: 12-17	1369	22,446,763	6,866,656	1292	23,129,799	5,784,549	1250	21,394,502	5,569,750
Age: 18-34	14,596	188,466,057	97,457,837	14,438	184,739,261	88,449,066	14,210	189,942,271	86,301,001
Age: 35-49	32,266	422,412,851	224,190,221	32,418	428,248,403	213,228,508	32,808	442,883,322	215,872,689
Age: 50-64	45,083	683,261,599	326,148,311	46,881	723,510,804	321,218,891	48,319	759,506,162	332,882,489
Age: ≥65	17,282	335,030,539	151,965,430	18,337	355,952,031	150,664,053	19,406	392,059,228	160,444,553
Sex: Male	66,675	985,672,854	483,701,798	68,495	1,031,191,774	469,764,712	70,062	1,085,381,926	484,048,549
Sex: Female	44,856	686,170,098	328,586,889	45,848	702,548,342	314,383,431	46,877	740,149,085	321,490,382
Race/ethnicity: White	64,037	900,755,778	444,319,962	65,168	929,818,276	432,255,960	66,134	975,463,043	444,631,224
Race/ethnicity: Black	26,131	452,723,637	211,726,515	26,845	468,781,508	198,616,162	27,479	484,960,413	201,696,556
Race/ethnicity: Hispanic	14,657	224,234,380	113,890,154	15,275	235,078,446	111,610,089	15,905	250,256,356	114,202,826
Race/ethnicity: Asian	5380	71,653,378	34,307,594	5698	76,497,941	33,953,309	6017	85,342,435	36,436,057
Race/ethnicity: Other/unknown	1326	22,475,779	8,044,462	1357	23,563,944	7,712,623	1404	29,508,764	8,572,268
Diagnosis: Diabetes	32,232	589,468,400	274,207,292	33,366	615,782,924	268,199,241	34,284	651,919,009	274,727,498
Diagnosis: Hypertension	24,139	356,884,975	181,977,428	24,639	366,468,820	172,282,667	25,138	375,894,263	175,875,005
Diagnosis: GN	20,323	246,646,057	126,308,544	20,641	246,835,429	120,694,085	20,989	269,743,094	125,092,260
Diagnosis: CKD	14,086	171,523,339	87,039,828	14,677	180,032,966	84,936,164	15,111	188,195,855	88,908,037
Diagnosis: Other	20,751	307,320,180	142,755,595	21,020	324,619,977	138,035,986	21,417	339,778,790	140,936,131

Table Econ 5 Per person per year calendar-year Medicare costs of kidney transplant recipients, 2012, 2013, and 2014
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Per person per year costs are given in $ units. Values for cells with 9 or fewer recipients are suppressed. CKD, cystic kidney disease; GN, glomerulonephritis.

Subgroup	2012 Patients, N	2012 PPPY $, Part A	2012 PPPY $, Part B	2013 Patients, N	2013 PPPY $, Part A	2013 PPPY $, Part B	2014 Patients, N	2014 PPPY $, Part A	2014 PPPY $, Part B
All recipients	111,531	16,579	8055	114,343	16,805	7601	116,939	17,262	7617
Age: 0-11	935	24,896	6967	977	21,396	5659	947	23,448	5306
Age: 12-17	1369	18,617	5695	1292	20,515	5131	1250	19,369	5042
Age: 18-34	14,596	14,247	7367	14,438	14,150	6775	14,210	14,739	6697
Age: 35-49	32,266	14,313	7596	32,418	14,453	7196	32,808	14,762	7196
Age: 50-64	45,083	16,693	7968	46,881	17,034	7563	48,319	17,306	7585
Age: ≥65	17,282	22,114	10,031	18,337	22,206	9399	19,406	23,017	9419
Sex: Male	66,675	16,396	8046	68,495	16,744	7628	70,062	17,183	7663
Sex: Female	44,856	16,849	8069	45,848	16,896	7561	46,877	17,379	7549
Race/ethnicity: White	64,037	15,433	7613	65,168	15,684	7291	66,134	16,170	7371
Race/ethnicity: Black	26,131	19,460	9101	26,845	19,675	8336	27,479	19,852	8256
Race/ethnicity: Hispanic	14,657	17,000	8635	15,275	17,146	8140	15,905	17,447	7962
Race/ethnicity: Asian	5380	14,828	7100	5698	14,944	6633	6017	15,789	6741
Race/ethnicity: Other/unknown	1326	18,897	6764	1357	19,244	6299	1404	23,551	6841
Diagnosis: Diabetes	32,232	20,391	9486	33,366	20,642	8990	34,284	21,174	8923
Diagnosis: Hypertension	24,139	16,430	8378	24,639	16,560	7785	25,138	16,620	7776
Diagnosis: GN	20,323	13,386	6855	20,641	13,156	6433	20,989	14,170	6571
Diagnosis: CKD	14,086	13,254	6726	14,677	13,442	6342	15,111	13,583	6417
Diagnosis: Other	20,751	16,310	7576	21,020	17,042	7247	21,417	17,463	7244

Table Econ 6 Per person per year Medicare costs of pancreas transplant recipients during the year prior to transplant
Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed.

Subgroup	Patients, N	Pre-tx, 365 days	Pre-tx,90 days	Pre-tx, 30 days
All recipients	2211	48,961	11,730	3275
Age: 0-11	0	*	*	*
Age: 12-17	0	*	*	*
Age: 18-34	535	58,825	14,017	4050
Age: 35-49	1258	48,058	11,571	3170
Age: 50-64	407	39,450	9320	2591
Age: ≥65	11	27,764	8245	2832
Sex: Male	1376	48,359	11,406	3225
Sex: Female	835	49,957	12,267	3358
Race/ethnicity: White	1392	44,588	10,736	3110
Race/ethnicity: Black	479	60,162	14,049	3961
Race/ethnicity: Hispanic	277	51,106	12,344	3092
Race/ethnicity: Asian	35	52,203	13,610	1987
Race/ethnicity: Other/unknown	28	50,523	13,369	3155
Diagnosis: Diabetes type 1	2003	48,718	11,674	3252
Diagnosis: Diabetes type 2	208	51,320	12,273	3492
Diagnosis: Other/unknown	0	*	*	*

Table Econ 7 Total and per person per year Medicare costs of pancreas transplant recipients in year 1 posttransplant
Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	2940	252,995,158	64,843,580	95,160	24,390
Age: 0-11	3	*	*	*	*
Age: 12-17	*	*	*	*	*
Age: 18-34	696	61,128,098	16,308,516	97,470	26,004
Age: 35-49	1669	137,604,657	36,209,219	91,397	24,050
Age: 50-64	557	51,680,011	11,897,596	101,734	23,421
Age: ≥65	14	1,553,718	303,798	111,723	21,845
Sex: Male	1856	151,783,484	40,009,430	90,803	23,935
Sex: Female	1084	101,211,673	24,834,150	102,539	25,160
Race/ethnicity: White	1852	156,406,728	39,273,089	93,724	23,534
Race/ethnicity: Black	633	57,186,923	15,024,017	99,480	26,135
Race/ethnicity: Hispanic	378	31,868,145	8,836,693	92,353	25,609
Race/ethnicity: Asian	46	4,570,966	1,060,119	109,886	25,485
Race/ethnicity: Other/unknown	31	2,962,395	649,662	104,693	22,960
Diagnosis: Diabetes type 1	2458	206,379,196	53,480,134	93,065	24,117
Diagnosis: Diabetes type 2	240	19,177,512	5,459,818	87,011	24,772
Diagnosis: Other/unknown	242	27,438,450	5,903,627	124,355	26,756

Table Econ 8 Total and per person per year Medicare costs of pancreas transplant recipients in year 2 posttransplant
Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 posttransplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewerrecipients are suppressed.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	2099	41,451,815	25,648,762	20,267	12,540
Age: 0-11	0	*	*	*	*
Age: 12-17	*	*	*	*	*
Age: 18-34	506	12,140,061	6,636,985	24,640	13,471
Age: 35-49	1179	20,927,801	14,257,720	18,180	12,385
Age: 50-64	405	7,889,654	4,656,205	20,062	11,840
Age: ≥65	8	*	*	*	*
Sex: Male	1321	22,293,123	15,368,414	17,292	11,921
Sex: Female	778	19,158,692	10,280,348	25,337	13,596
Race/ethnicity: White	1324	26,354,956	15,583,051	20,505	12,124
Race/ethnicity: Black	458	10,145,137	6,236,908	22,621	13,906
Race/ethnicity: Hispanic	266	3,989,059	3,255,833	15,260	12,455
Race/ethnicity: Asian	27	485,071	320,957	18,613	12,316
Race/ethnicity: Other/unknown	24	477,593	252,012	19,845	10,472
Diagnosis: Diabetes type 1	1755	34,167,912	21,241,099	20,003	12,435
Diagnosis: Diabetes type 2	170	2,432,591	2,132,196	14,508	12,716
Diagnosis: Other/unknown	174	4,851,312	2,275,467	28,627	13,427

Table Econ 9 Total calendar-year Medicare costs of pancreas transplant recipients, 2012, 2013, and 2014
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units. Values for cells with 9 or fewer recipients are suppressed.

Subgroup	2012 Patients, N	2012 Total $, Part A	2012 Total $, Part B	2013 Patients, N	2013 Total $, Part A	2013 Total $, Part B	2014 Patients, N	2014 Total $, Part A	2014 Total $, Part B
All recipients	8080	156,021,870	66,691,146	8233	161,551,798	64,588,862	8305	166,969,332	65,380,677
Age: 0-11	3	*	*	5	*	*	4	*	*
Age: 12-17	11	601,257	118,726	11	513,733	127,255	8	*	*
Age: 18-34	1973	43,983,970	17,645,711	1971	45,463,182	16,731,048	1994	47,919,651	16,679,800
Age: 35-49	4650	83,807,576	37,521,611	4729	86,256,088	36,391,146	4728	89,215,228	36,914,000
Age: 50-64	1430	27,133,233	11,186,976	1498	27,941,343	11,025,370	1553	28,827,323	11,459,788
Age: ≥65	13	391,707	136,836	19	1,025,991	215,071	18	428,432	197,679
Sex: Male	4826	88,633,008	39,127,308	4947	90,702,770	38,086,949	4958	95,779,140	38,572,642
Sex: Female	3254	67,388,862	27,563,838	3286	70,849,028	26,501,913	3347	71,190,192	26,808,035
Race/ethnicity: White	6141	111,262,149	47,834,884	6190	115,497,356	46,072,041	6163	112,502,579	45,587,767
Race/ethnicity: Black	1140	28,001,301	11,433,087	1184	28,407,622	10,856,626	1249	35,777,671	11,869,609
Race/ethnicity: Hispanic	665	13,739,983	6,297,548	711	14,560,469	6,372,108	738	15,507,992	6,696,509
Race/ethnicity: Asian	78	1,591,392	617,154	89	1,937,364	742,134	101	2,423,063	829,464
Race/ethnicity: Other/unknown	56	1,427,045	508,473	59	1,148,987	545,953	54	758,027	397,327
Diagnosis: Diabetes type 1	6610	125,550,152	53,901,834	6707	130,069,622	52,186,483	6779	131,591,773	52,390,606
Diagnosis: Diabetes type 2	532	9,838,294	4,609,657	574	10,437,111	4,770,281	583	13,574,184	5,249,586
Diagnosis: Other/unknown	938	20,633,425	8,179,656	952	21,045,065	7,632,098	943	21,803,374	7,740,485

Table Econ 10 Per person per year calendar-year Medicare costs of pancreas transplant recipients, 2012, 2013, and 2014
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Per person per year costs are given in $ units. Values for cells with 9 or fewer recipients are suppressed.

Subgroup	2012 Patients, N	2012 PPPY $, Part A	2012 PPPY $, Part B	2013 Patients, N	2013 PPPY $, Part A	2013 PPPY $, Part B	2014 Patients, N	2014 PPPY $, Part A	2014 PPPY $, Part B
All recipients	8080	20,831	8904	8233	21,104	8438	8305	21,599	8457
Age: 0-11	3	*	*	5	*	*	4	*	*
Age: 12-17	11	54,660	10,793	11	50,570	12,526	8	*	*
Age: 18-34	1973	23,925	9598	1971	24,709	9093	1994	25,893	9013
Age: 35-49	4650	19,377	8675	4729	19,576	8259	4728	20,120	8325
Age: 50-64	1430	20,841	8593	1498	20,270	7998	1553	20,348	8089
Age: ≥65	13	37,136	12,973	19	63,322	13,274	18	25,044	11,556
Sex: Male	4826	19,870	8772	4947	19,757	8296	4958	20,806	8379
Sex: Female	3254	22,246	9099	3286	23,123	8649	3347	22,766	8573
Race/ethnicity: White	6141	19,427	8352	6190	19,949	7958	6163	19,470	7890
Race/ethnicity: Black	1140	27,145	11,084	1184	26,279	10,043	1249	31,581	10,477
Race/ethnicity: Hispanic	665	22,570	10,345	711	22,278	9749	738	22,792	9842
Race/ethnicity: Asian	78	21,899	8493	89	25,108	9618	101	27,358	9365
Race/ethnicity: Other/unknown	56	28,633	10,202	59	21,416	10,176	54	15,004	7865
Diagnosis: Diabetes type 1	6610	20,524	8811	6707	20,827	8356	6779	20,841	8297
Diagnosis: Diabetes type 2	532	20,193	9461	574	19,965	9125	583	25,438	9838
Diagnosis: Other/unknown	938	23,305	9239	952	23,732	8606	943	24,699	8768

Table Econ 11 Per person per year Medicare costs of liver transplant recipients during the year prior to transplant
Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. ALD, alcoholic liver disease; HCV, hepatitis C virus.

Subgroup	Patients, N	Pre-tx, 365 days	Pre-tx,90 days	Pre-tx, 30 days
All recipients	5724	50,003	21,578	8274
Age: 0-11	18	92,746	29,103	6557
Age: 12-17	3	*	*	*
Age: 18-34	143	53,554	21,879	8698
Age: 35-49	656	58,695	25,762	9924
Age: 50-64	2862	50,544	21,601	8286
Age: ≥65	2042	45,899	20,151	7723
Sex: Male	3688	48,897	21,278	8252
Sex: Female	2036	52,014	22,125	8314
Race/ethnicity: White	4002	48,867	21,208	8136
Race/ethnicity: Black	584	51,882	21,339	8073
Race/ethnicity: Hispanic	843	55,882	24,475	9694
Race/ethnicity: Asian	227	41,210	17,111	6417
Race/ethnicity: Other/unknown	68	57,707	24,724	6716
Diagnosis: Acute liver failure	108	49,621	24,198	10,217
Diagnosis: HCV	1596	53,655	23,399	8895
Diagnosis: ALD	918	53,323	23,787	9386
Diagnosis: Chol. disease	411	48,081	21,344	8685
Diagnosis: Malignancy	1224	39,481	14,495	5402
Diagnosis: Other/unknown	1467	53,516	24,140	9040
MELD: Status 1A/1B	51	34,274	20,100	10,616
MELD: ≥ 35	960	62,751	34,832	13,972
MELD: 30-34	895	57,961	27,819	10,775
MELD: 15-29	3643	45,329	17,057	6321
MELD: < 15	173	43,669	13,800	4186
MELD: Other/unknown	2	*	*	*

Table Econ 12 Total and per person per year Medicare costs of liver transplant recipients in year 1 posttransplant
Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipientss are suppressed. ALD, alcoholic liver disease; HCV, hepatitis C virus.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	6991	1,018,940,082	163,721,840	161,578	25,962
Age: 0-11	22	4,448,446	769,938	210,758	36,478
Age: 12-17	4	*	*	*	*
Age: 18-34	172	27,531,950	4,021,111	174,789	25,528
Age: 35-49	831	123,459,585	20,049,502	164,818	26,766
Age: 50-64	3535	515,972,640	81,107,900	161,368	25,366
Age: ≥65	2427	346,999,332	57,702,921	159,321	26,494
Sex: Male	4533	654,564,276	105,051,952	159,650	25,622
Sex: Female	2458	364,375,806	58,669,888	165,159	26,593
Race/ethnicity: White	4882	687,106,693	112,579,398	156,418	25,628
Race/ethnicity: Black	716	114,375,126	17,150,146	176,724	26,499
Race/ethnicity: Hispanic	1030	163,090,630	25,532,105	174,140	27,262
Race/ethnicity: Asian	282	42,560,348	6,553,599	165,787	25,528
Race/ethnicity: Other/unknown	81	11,807,286	1,906,591	161,786	26,125
Diagnosis: Acute liver failure	143	26,473,167	3,489,806	217,403	28,659
Diagnosis: HCV	1906	289,359,222	44,511,460	170,485	26,225
Diagnosis: ALD	1138	171,901,874	26,500,140	163,968	25,277
Diagnosis: Chol. disease	503	73,967,191	11,954,878	168,470	27,229
Diagnosis: Malignancy	1524	190,930,207	34,068,434	136,015	24,270
Diagnosis: Other/unknown	1777	266,308,421	43,197,122	166,862	27,066
MELD: Status 1A/1B	64	14,018,838	1,750,351	261,425	32,641
MELD: ≥ 35	1082	233,747,103	30,075,605	252,227	32,453
MELD: 30-34	1016	163,436,211	24,986,306	179,343	27,418
MELD: 15-29	4597	572,385,082	100,914,314	136,164	24,006
MELD: < 15	228	34,609,497	5,878,303	167,291	28,414
MELD: Other/unknown	4	*	*	*	*

Table Econ 13 Total and per person per year Medicare costs of liver transplant recipients in year 2 posttransplant
Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 posttransplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. ALD, alcoholic liver disease; HCV, hepatitis C virus.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	4829	90,234,130	44,392,243	19,282	9486
Age: 0-11	15	766,775	167,371	50,979	11,128
Age: 12-17	3	*	*	*	*
Age: 18-34	125	2,558,577	1,091,583	21,100	9002
Age: 35-49	598	10,859,561	5,540,456	18,621	9500
Age: 50-64	2488	50,214,003	22,446,959	20,792	9295
Age: ≥65	1600	25,793,227	15,133,997	16,727	9814
Sex: Male	3150	57,791,738	28,354,346	18,957	9301
Sex: Female	1679	32,442,391	16,037,896	19,890	9833
Race/ethnicity: White	3363	59,856,884	31,048,135	18,284	9484
Race/ethnicity: Black	498	11,464,909	4,699,942	24,158	9903
Race/ethnicity: Hispanic	709	14,419,976	6,536,099	21,030	9532
Race/ethnicity: Asian	201	3,857,220	1,737,366	20,447	9210
Race/ethnicity: Other/unknown	58	635,140	370,700	11,151	6508
Diagnosis: Acute liver failure	94	1,635,381	847,422	18,144	9402
Diagnosis: HCV	1278	26,091,360	10,961,236	21,182	8899
Diagnosis: ALD	795	14,632,847	6,927,205	18,881	8938
Diagnosis: Chol. disease	344	6,785,491	3,102,142	20,399	9326
Diagnosis: Malignancy	1086	20,600,662	10,235,036	19,804	9839
Diagnosis: Other/unknown	1232	20,488,389	12,319,202	16,935	10,183
MELD: Status 1A/1B	44	728,868	553,843	16,741	12,721
MELD: ≥ 35	649	12,755,467	6,399,563	20,357	10,213
MELD: 30-34	673	14,848,364	6,270,973	22,943	9690
MELD: 15-29	3296	57,678,461	29,689,159	18,030	9281
MELD: < 15	163	4,080,534	1,441,874	25,622	9054
MELD: Other/unknown	4	*	*	*	*

Table Econ 14 Total calendar-year Medicare costs of liver transplant recipients, 2012, 2013, and 2014
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units. Values for cells with 9 or fewer recipient are suppressed. ALD, alcoholic liver disease; HCV, hepatitis C virus.

Subgroup	2012 Patients, N	2012 Total $, Part A	2012 Total $, Part B	2013 Patients, N	2013 Total $, Part A	2013 Total $, Part B	2014 Patients, N	2014 Total $, Part A	2014 Total $, Part B
All recipients	27,775	510,498,683	159,560,771	29,240	547,526,363	161,641,519	30,641	570,004,854	169,425,166
Age: 0-11	120	4,227,560	918,871	135	4,067,393	862,493	141	4,002,779	792,338
Age: 12-17	102	1,976,235	481,795	102	2,092,991	534,345	104	2,751,566	592,990
Age: 18-34	1080	22,727,683	6,198,007	1093	19,508,477	5,754,130	1124	21,880,850	5,908,291
Age: 35-49	6212	103,684,898	31,799,439	6266	104,079,828	30,861,731	6281	103,480,765	31,131,979
Age: 50-64	16,191	275,369,066	87,352,821	17,185	300,280,150	88,589,232	18,147	311,315,484	92,662,285
Age: ≥65	4070	102,513,242	32,809,838	4459	117,497,524	35,039,588	4844	126,573,410	38,337,284
Sex: Male	18,117	329,472,491	101,243,582	19,058	348,801,740	102,627,283	19,989	363,516,531	108,100,617
Sex: Female	9658	181,026,192	58,317,189	10,182	198,724,623	59,014,236	10,652	206,488,323	61,324,550
Race/ethnicity: White	20,869	362,166,137	118,155,629	21,932	390,692,266	120,417,465	22,910	410,387,468	126,787,193
Race/ethnicity: Black	2199	53,647,029	13,922,881	2378	57,040,298	13,802,035	2516	58,403,532	14,538,484
Race/ethnicity: Hispanic	3411	71,682,855	20,577,800	3553	75,090,540	20,553,382	3757	76,786,627	20,941,913
Race/ethnicity: Asian	1052	19,502,170	5,752,120	1114	19,086,746	5,556,042	1176	18,526,506	5,834,294
Race/ethnicity: Other/unknown	244	3,500,492	1,152,340	263	5,616,513	1,312,594	282	5,900,721	1,323,282
Diagnosis: Acute liver failure	1190	18,655,333	5,480,391	1207	17,776,468	5,346,800	1218	19,242,250	5,476,174
Diagnosis: HCV	6981	141,724,832	39,737,762	7316	145,201,885	39,919,553	7669	151,251,245	42,067,034
Diagnosis: ALD	5432	92,578,857	28,366,327	5663	102,936,784	28,389,166	5877	109,921,192	29,957,716
Diagnosis: Chol. disease	3146	47,980,441	16,544,113	3235	52,556,843	16,742,389	3351	52,955,385	16,994,947
Diagnosis: Malignancy	3448	68,176,774	21,986,792	3825	70,948,707	21,774,891	4204	75,701,393	24,100,961
Diagnosis: Other/unknown	7578	141,382,446	47,445,386	7996	158,105,675	49,468,720	8322	160,933,390	50,828,334
MELD: Status 1A/1B	1362	23,301,506	6,876,284	1345	19,923,791	6,167,795	1347	22,423,214	6,361,098
MELD: ≥ 35	2617	72,718,407	18,623,228	3041	95,200,982	21,042,700	3582	110,273,161	24,689,647
MELD: 30-34	2236	57,651,841	15,378,997	2615	60,754,400	16,094,731	2933	66,518,394	18,126,928
MELD: 15-29	13,459	231,464,004	76,378,013	14,429	244,711,292	78,135,510	15,327	254,705,445	82,713,071
MELD: < 15	1307	21,766,883	7,206,445	1347	24,926,194	7,313,017	1377	23,625,208	7,578,541
MELD: Other/unknown	6794	103,596,042	35,097,804	6465	102,009,704	32,887,766	6075	92,459,432	29,955,882

Table Econ 15 Per person per year calendar-year Medicare costs of liver transplant recipients, 2012, 2013, and 2014
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Per person per year costs are given in $ units. Values for cells with 9 or fewer recipients are suppressed. ALD, alcoholic liver disease; HCV, hepatitis C virus.

Subgroup	2012 Patients, N	2012 PPPY $, Part A	2012 PPPY $, Part B	2013 Patients, N	2013 PPPY $, Part A	2013 PPPY $, Part B	2014 Patients, N	2014 PPPY $, Part A	2014 PPPY $, Part B
All recipients	27,775	19,714	6162	29,240	20,189	5960	30,641	20,036	5956
Age: 0-11	120	37,061	8055	135	31,556	6692	141	29,032	5747
Age: 12-17	102	19,818	4831	102	21,103	5388	104	27,641	5957
Age: 18-34	1080	22,061	6016	1093	18,742	5528	1124	20,749	5603
Age: 35-49	6212	17,561	5386	6266	17,517	5194	6281	17,384	5230
Age: 50-64	16,191	18,180	5767	17,185	18,737	5528	18,147	18,351	5462
Age: ≥65	4070	28,472	9113	4459	30,262	9025	4844	29,857	9043
Sex: Male	18,117	19,538	6004	19,058	19,731	5805	19,989	19,640	5841
Sex: Female	9658	20,042	6457	10,182	21,047	6250	10,652	20,774	6170
Race/ethnicity: White	20,869	18,583	6063	21,932	19,168	5908	22,910	19,288	5959
Race/ethnicity: Black	2199	26,536	6887	2378	26,298	6363	2516	25,401	6323
Race/ethnicity: Hispanic	3411	22,639	6499	3553	22,912	6271	3757	21,956	5988
Race/ethnicity: Asian	1052	19,626	5789	1114	18,250	5312	1176	16,655	5245
Race/ethnicity: Other/unknown	244	15,570	5126	263	22,916	5355	282	22,501	5046
Diagnosis: Acute liver failure	1190	16,384	4813	1207	15,432	4642	1218	16,566	4715
Diagnosis: HCV	6981	22,006	6170	7316	21,531	5919	7669	21,455	5967
Diagnosis: ALD	5432	18,200	5577	5663	19,540	5389	5877	19,999	5451
Diagnosis: Chol. disease	3146	15,994	5515	3235	17,158	5466	3351	16,763	5380
Diagnosis: Malignancy	3448	21,794	7028	3825	20,596	6321	4204	19,839	6316
Diagnosis: Other/unknown	7578	19,908	6681	7996	21,225	6641	8322	20,723	6545
MELD: Status 1A/1B	1362	17,895	5281	1345	15,533	4809	1347	17,577	4986
MELD: ≥ 35	2617	30,780	7883	3041	35,369	7818	3582	34,142	7644
MELD: 30-34	2236	28,980	7730	2615	25,913	6865	2933	24,988	6810
MELD: 15-29	13,459	18,535	6116	14,429	18,320	5850	15,327	17,953	5830
MELD: < 15	1307	17,456	5779	1347	19,392	5689	1377	18,100	5806
MELD: Other/unknown	6794	15,921	5394	6465	16,563	5340	6075	15,973	5175

Table Econ 16 Per person per year Medicare costs of intestinal transplant recipients during the year prior to transplant
Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. IN, intestine without liver; IN-LI, intestine with liver; NEC, necrotizing enterocolitis; SGS, short-gut syndrome.

Subgroup	Patients, N	Pre-tx, 365 days	Pre-tx,90 days	Pre-tx, 30 days
All recipients	58	130,057	36,379	12,226
Age: 0-11	2	*	*	*
Age: 12-17	0	*	*	*
Age: 18-34	11	142,159	35,590	14,081
Age: 35-49	19	143,782	43,213	13,190
Age: 50-64	23	118,150	33,936	11,300
Age: ≥65	3	*	*	*
Sex: Male	23	108,991	31,973	12,423
Sex: Female	35	143,900	39,275	12,096
Race/ethnicity: White	46	132,258	36,743	12,022
Race/ethnicity: Black	2	*	*	*
Race/ethnicity: Hispanic	5	*	*	*
Race/ethnicity: Asian	3	*	*	*
Race/ethnicity: Other/unknown	2	*	*	*
Diagnosis: NEC	*	*	*	*
Diagnosis: Congenital SGS	0	*	*	*
Diagnosis: Other SGS	45	131,919	35,093	12,330
Diagnosis: Pseudo-obstruction	3	*	*	*
Diagnosis: Enteropathies	0	*	*	*
Diagnosis: Other/unknown	9	*	*	*
Tx type: IN	44	145,386	41,467	12,959
Tx type: IN-LI	14	81,879	20,391	9919

Table Econ 17 Total and per person per year Medicare costs of intestine transplant recipients in year 1 posttransplant
Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. IN, intestine without liver; IN-LI, intestine with liver; NEC, necrotizing enterocolitis; SGS, short-gut syndrome.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	71	19,872,400	2,501,504	348,689	43,892
Age: 0-11	2	*	*	*	*
Age: 12-17	0	*	*	*	*
Age: 18-34	11	3,449,066	447,237	542,867	70,393
Age: 35-49	23	5,083,714	738,947	240,326	34,933
Age: 50-64	29	9,333,470	1,079,392	398,960	46,139
Age: ≥65	6	*	*	*	*
Sex: Male	29	8,047,893	1,001,739	331,432	41,254
Sex: Female	42	11,824,507	1,499,764	361,500	45,851
Race/ethnicity: White	59	16,206,027	2,001,795	337,587	41,699
Race/ethnicity: Black	2	*	*	*	*
Race/ethnicity: Hispanic	5	*	*	*	*
Race/ethnicity: Asian	3	*	*	*	*
Race/ethnicity: Other/unknown	2	*	*	*	*
Diagnosis: NEC	*	*	*	*	*
Diagnosis: Congenital SGS	0	*	*	*	*
Diagnosis: Other SGS	53	14,397,767	1,757,841	345,486	42,181
Diagnosis: Pseudo-obstruction	4	*	*	*	*
Diagnosis: Enteropathies	0	*	*	*	*
Diagnosis: Other/unknown	13	4,279,642	542,311	351,501	44,542
Tx type: IN	51	14,177,604	1,849,612	352,413	45,976
Tx type: IN-LI	20	5,694,796	651,891	339,752	38,892

Table Econ 18 Total and per person per year Medicare costs of intestine transplant recipients in year 2 posttransplant
Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 posttransplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. IN, intestine without liver; IN-LI, intestine with liver; NEC, necrotizing enterocolitis; SGS, short-gut syndrome.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	44	3,272,122	850,484	85,670	22,267
Age: 0-11	*	*	*	*	*
Age: 12-17	0	*	*	*	*
Age: 18-34	4	*	*	*	*
Age: 35-49	18	1,195,228	485,983	76,096	30,941
Age: 50-64	17	1,071,759	212,970	71,555	14,219
Age: ≥65	4	*	*	*	*
Sex: Male	18	592,212	263,851	38,292	17,060
Sex: Female	26	2,679,910	586,633	117,908	25,810
Race/ethnicity: White	37	2,890,561	709,343	90,625	22,239
Race/ethnicity: Black	*	*	*	*	*
Race/ethnicity: Hispanic	3	*	*	*	*
Race/ethnicity: Asian	*	*	*	*	*
Race/ethnicity: Other/unknown	2	*	*	*	*
Diagnosis: NEC	0	*	*	*	*
Diagnosis: Congenital SGS	0	*	*	*	*
Diagnosis: Other SGS	33	2,298,935	581,288	83,419	21,093
Diagnosis: Pseudo-obstruction	*	*	*	*	*
Diagnosis: Enteropathies	0	*	*	*	*
Diagnosis: Other/unknown	10	853,010	168,955	88,552	17,539
Tx type: IN	31	2,342,205	660,325	91,659	25,841
Tx type: IN-LI	13	929,917	190,159	73,563	15,043

Table Econ 19 Total calendar-year Medicare costs of intestine transplant recipients, 2012, 2013, and 2014
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units. Values for cells with 9 or fewer recipients are suppressed. IN, intestine without liver; IN-LI, intestine with liver; NEC, necrotizing enterocolitis; SGS, short-gut syndrome.

Subgroup	2012 Patients, N	2012 Total $, Part A	2012 Total $, Part B	2013 Patients, N	2013 Total $, Part A	2013 Total $, Part B	2014 Patients, N	2014 Total $, Part A	2014 Total $, Part B
All recipients	246	8,361,754	2,810,435	272	11,084,712	3,039,910	270	10,946,047	2,363,209
Age: 0-11	6	*	*	8	*	*	6	*	*
Age: 12-17	6	*	*	5	*	*	5	*	*
Age: 18-34	69	2,900,274	950,296	72	3,602,405	976,287	61	2,463,021	532,280
Age: 35-49	93	2,564,701	1,011,988	104	3,128,746	1,183,547	107	3,337,706	913,515
Age: 50-64	65	2,067,618	604,694	77	3,524,048	674,859	84	4,259,959	697,853
Age: ≥65	7	*	*	6	*	*	7	*	*
Sex: Male	104	3,953,727	1,151,106	115	3,744,437	1,164,700	117	4,205,122	957,224
Sex: Female	142	4,408,027	1,659,330	157	7,340,275	1,875,210	153	6,740,924	1,405,985
Race/ethnicity: White	205	6,598,548	2,334,754	223	8,992,434	2,454,520	216	9,059,696	1,892,356
Race/ethnicity: Black	25	972,103	263,666	28	1,235,735	293,643	33	1,536,841	296,956
Race/ethnicity: Hispanic	11	369,713	102,670	16	345,121	216,092	18	333,637	160,550
Race/ethnicity: Asian	2	*	*	2	*	*	2	*	*
Race/ethnicity: Other/unknown	3	*	*	3	*	*	*	*	*
Diagnosis: NEC	2	*	*	4	*	*	4	*	*
Diagnosis: Congenital SGS	4	*	*	5	*	*	4	*	*
Diagnosis: Other SGS	175	6,233,299	1,780,626	195	7,622,251	1,901,472	192	7,664,728	1,530,274
Diagnosis: Pseudo-obstruction	23	903,599	460,417	26	1,083,892	476,323	25	1,160,071	408,361
Diagnosis: Enteropathies	0	*	*	0	*	*	0	*	*
Diagnosis: Other/unknown	42	1,049,570	524,460	42	2,050,866	622,648	45	1,934,133	380,743
Tx type: IN	153	5,741,814	1,759,230	176	8,008,316	2,052,101	159	6,299,324	1,389,364
Tx type: IN-LI	93	2,619,940	1,051,205	96	3,076,396	987,809	111	4,646,723	973,845

Table Econ 20 Per person per year calendar-year Medicare costs of intestine transplant recipients, 2012, 2013, and 2014
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Per person per year osts are given in $ units. Values for cells with 9 or fewer recipients are suppressed. IN, intestine without liver; IN-LI, intestine with liver; NEC, necrotizing enterocolitis; SGS, short-gut syndrome.

Subgroup	2012 Patients, N	2012 PPPY $, Part A	2012 PPPY $, Part B	2013 Patients, N	2013 PPPY $, Part A	2013 PPPY $, Part B	2014 Patients, N	2014 PPPY $, Part A	2014 PPPY $, Part B
All recipients	246	36,611	12,305	272	45,817	12,565	270	46,039	9940
Age: 0-11	6	*	*	8	*	*	6	*	*
Age: 12-17	6	*	*	5	*	*	5	*	*
Age: 18-34	69	45,301	14,843	72	55,129	14,940	61	44,735	9668
Age: 35-49	93	29,038	11,458	104	33,587	12,705	107	34,549	9456
Age: 50-64	65	35,187	10,291	77	53,815	10,306	84	61,558	10,084
Age: ≥65	7	*	*	6	*	*	7	*	*
Sex: Male	104	41,552	12,098	115	36,842	11,460	117	41,669	9485
Sex: Female	142	33,083	12,454	157	52,319	13,366	153	49,263	10,275
Race/ethnicity: White	205	34,590	12,239	223	45,297	12,364	216	47,742	9972
Race/ethnicity: Black	25	43,144	11,702	28	48,820	11,601	33	50,463	9751
Race/ethnicity: Hispanic	11	34,442	9565	16	26,162	16,381	18	22,942	11,040
Race/ethnicity: Asian	2	*	*	2	*	*	2	*	*
Race/ethnicity: Other/unknown	3	*	*	3	*	*	*	*	*
Diagnosis: NEC	2	*	*	4	*	*	4	*	*
Diagnosis: Congenital SGS	4	*	*	5	*	*	4	*	*
Diagnosis: Other SGS	175	38,194	10,911	195	44,015	10,980	192	45,692	9122
Diagnosis: Pseudo-obstruction	23	39,828	20,294	26	45,928	20,183	25	46,587	16,399
Diagnosis: Enteropathies	0	*	*	0	*	*	0	*	*
Diagnosis: Other/unknown	42	28,726	14,354	42	53,267	16,172	45	50,799	10,000
Tx type: IN	153	39,830	12,203	176	51,461	13,187	159	44,651	9848
Tx type: IN-LI	93	31,104	12,480	96	35,641	11,444	111	48,066	10,073

Table Econ 21 Per person per year Medicare costs of heart transplant recipients during the year prior to transplant
Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CAD, coronary artery disease.

Subgroup	Patients, N	Pre-tx, 365 days	Pre-tx,90 days	Pre-tx, 30 days
All recipients	2675	111,902	26,923	7194
Age: 0-11	0	*	*	*
Age: 12-17	0	*	*	*
Age: 18-34	128	107,087	30,180	7539
Age: 35-49	427	112,122	27,850	6910
Age: 50-64	1108	113,901	28,084	7287
Age: ≥65	1012	110,231	24,844	7167
Sex: Male	2049	116,201	27,264	7020
Sex: Female	626	97,844	25,812	7761
Race/ethnicity: White	1817	108,920	25,664	7004
Race/ethnicity: Black	592	118,863	29,579	7681
Race/ethnicity: Hispanic	182	124,360	32,039	7857
Race/ethnicity: Asian	62	96,188	23,710	6805
Race/ethnicity: Other/unknown	22	112,558	26,319	5338
Diagnosis: CAD	1225	116,508	25,457	7093
Diagnosis: Cardiomyopathy	1294	111,208	28,426	7280
Diagnosis: Congenital	54	65,516	25,925	7947
Diagnosis: Valvular	57	77,124	21,557	7236
Diagnosis: Other/unknown	45	106,667	31,636	6468

Table Econ 22 Total and per person per year Medicare costs among heart transplant recipients in year 1 posttransplant
Costs among recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after a transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CAD, coronary artery disease.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	3135	775,428,078	99,708,887	270,162	34,739
Age: 0-11	*	*	*	*	*
Age: 12-17	*	*	*	*	*
Age: 18-34	157	39,885,874	5,141,988	271,809	35,041
Age: 35-49	511	133,357,767	16,441,155	282,262	34,799
Age: 50-64	1315	320,964,196	41,140,019	264,861	33,949
Age: ≥65	1150	279,531,496	36,927,100	269,506	35,603
Sex: Male	2391	591,036,669	75,913,330	269,083	34,561
Sex: Female	744	184,391,409	23,795,557	273,681	35,318
Race/ethnicity: White	2127	521,625,295	67,423,902	265,869	34,366
Race/ethnicity: Black	687	170,882,620	21,955,867	278,025	35,722
Race/ethnicity: Hispanic	225	56,938,270	7,027,246	280,057	34,564
Race/ethnicity: Asian	70	19,640,896	2,534,209	294,074	37,943
Race/ethnicity: Other/unknown	26	6,340,997	767,664	269,374	32,611
Diagnosis: CAD	1441	352,716,140	45,714,559	268,904	34,852
Diagnosis: Cardiomyopathy	1517	372,597,344	47,984,053	266,134	34,273
Diagnosis: Congenital	65	19,658,439	2,312,635	347,912	40,929
Diagnosis: Valvular	62	16,438,516	1,996,704	288,714	35,069
Diagnosis: Other/unknown	50	14,017,640	1,700,937	311,030	37,741

Table Econ 23 Total and per person per year Medicare costs among heart transplant recipients in year 2 posttransplant
Costs among recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 posttransplant. Costs incurred after a transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CAD, coronary artery disease.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	2223	48,323,943	29,648,299	22,240	13,645
Age: 0-11	*	*	*	*	*
Age: 12-17	*	*	*	*	*
Age: 18-34	116	2,827,884	1,413,433	25,069	12,530
Age: 35-49	367	10,059,429	5,007,359	28,462	14,168
Age: 50-64	959	20,905,918	12,753,887	22,350	13,635
Age: ≥65	779	14,435,335	10,444,040	18,763	13,575
Sex: Male	1697	36,026,414	22,250,074	21,699	13,402
Sex: Female	526	12,297,529	7,398,225	23,993	14,434
Race/ethnicity: White	1529	33,233,047	20,435,955	22,259	13,688
Race/ethnicity: Black	465	10,498,539	6,330,952	23,009	13,875
Race/ethnicity: Hispanic	163	3,406,853	2,053,002	21,334	12,856
Race/ethnicity: Asian	49	786,535	615,219	16,715	13,075
Race/ethnicity: Other/unknown	17	398,969	213,172	23,791	12,712
Diagnosis: CAD	1032	22,921,962	13,856,199	22,701	13,723
Diagnosis: Cardiomyopathy	1071	22,673,293	14,194,433	21,638	13,547
Diagnosis: Congenital	45	954,969	678,991	22,107	15,718
Diagnosis: Valvular	43	460,123	511,691	10,671	11,867
Diagnosis: Other/unknown	32	1,313,595	406,986	45,417	14,071

Table Econ 24 Total calendar-year Medicare costs of heart transplant recipients, 2012, 2013, and 2014
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units. Values for cells with 9 or fewer recipients are suppressed. CAD, coronary artery disease.

Subgroup	2012 Patients, N	2012 Total $, Part A	2012 Total $, Part B	2013 Patients, N	2013 Total $, Part A	2013 Total $, Part B	2014 Patients, N	2014 Total $, Part A	2014 Total $, Part B
All recipients	13,541	345,446,387	104,757,701	13,763	359,290,977	104,691,809	14,130	376,908,810	108,565,030
Age: 0-11	52	1,468,803	273,893	54	1,426,327	344,515	55	1,368,903	266,478
Age: 12-17	55	1,035,810	210,124	54	922,680	260,911	60	1,570,296	290,777
Age: 18-34	871	22,748,268	5,727,948	828	20,796,467	5,569,564	871	21,847,157	6,128,413
Age: 35-49	2802	62,862,167	18,722,347	2902	70,927,670	19,068,683	2925	71,385,553	18,730,105
Age: 50-64	7723	172,983,869	56,077,176	7716	178,002,913	55,331,747	7783	180,393,204	55,992,050
Age: ≥65	2038	84,347,470	23,746,212	2209	87,214,919	24,116,390	2436	100,343,697	27,157,207
Sex: Male	10,650	265,095,197	81,376,270	10,826	277,458,226	81,238,876	11,036	287,504,490	84,140,324
Sex: Female	2891	80,351,190	23,381,430	2937	81,832,750	23,452,934	3094	89,404,320	24,424,707
Race/ethnicity: White	10,416	248,158,147	79,146,425	10,481	257,443,553	78,387,058	10,615	259,995,379	79,615,650
Race/ethnicity: Black	1973	65,572,876	16,662,205	2107	72,066,181	17,713,383	2269	80,926,613	19,476,783
Race/ethnicity: Hispanic	810	20,943,363	6,230,031	803	18,290,476	5,738,558	862	24,322,692	6,512,170
Race/ethnicity: Asian	258	8,674,229	2,142,749	278	9,129,743	2,136,563	295	8,802,027	2,212,407
Race/ethnicity: Other/unknown	84	2,097,772	576,292	94	2,361,023	716,247	89	2,862,099	748,020
Diagnosis: CAD	6451	166,632,578	51,733,947	6432	165,357,735	49,699,757	6448	166,842,747	50,334,415
Diagnosis: Cardiomyopathy	6262	156,571,038	46,751,331	6493	172,535,941	48,576,424	6800	187,969,481	51,824,727
Diagnosis: Congenital	303	8,737,325	2,169,353	312	6,822,064	2,386,986	334	8,423,581	2,269,200
Diagnosis: Valvular	334	7,722,114	2,670,429	327	7,671,297	2,482,932	339	7,833,377	2,619,495
Diagnosis: Other/unknown	191	5,783,331	1,432,641	199	6,903,939	1,545,711	209	5,839,624	1,517,193

Table Econ 25 Per person per year calendar-year Medicare costs for heart transplant recipients, 2012, 2013, and 2014
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Per person per year costs are given in $ units. Values for cells with 9 or fewer reciepients are suppressed. CAD, coronary artery disease.

Subgroup	2012 Patients, N	2012 PPPY $, Part A	2012 PPPY $, Part B	2013 Patients, N	2013 PPPY $, Part A	2013 PPPY $, Part B	2014 Patients, N	2014 PPPY $, Part A	2014 PPPY $, Part B
All recipients	13,541	27,448	8324	13,763	28,139	8199	14,130	28,861	8313
Age: 0-11	52	28,952	5399	54	27,500	6642	55	25,824	5027
Age: 12-17	55	19,242	3903	54	17,355	4908	60	27,574	5106
Age: 18-34	871	27,856	7014	828	26,494	7095	871	26,774	7510
Age: 35-49	2802	23,694	7057	2902	26,089	7014	2925	26,075	6842
Age: 50-64	7723	24,019	7786	7716	24,705	7679	7783	24,919	7735
Age: ≥65	2038	46,621	13,125	2209	44,620	12,338	2436	46,520	12,590
Sex: Male	10,650	26,747	8211	10,826	27,656	8098	11,036	28,190	8250
Sex: Female	2891	30,047	8743	2937	29,909	8572	3094	31,249	8537
Race/ethnicity: White	10,416	25,495	8131	10,481	26,446	8052	10,615	26,427	8092
Race/ethnicity: Black	1973	36,632	9308	2107	37,134	9127	2269	39,088	9407
Race/ethnicity: Hispanic	810	28,039	8341	803	24,322	7631	862	30,694	8218
Race/ethnicity: Asian	258	36,699	9066	278	35,617	8335	295	31,914	8022
Race/ethnicity: Other/unknown	84	26,763	7352	94	27,869	8455	89	34,587	9039
Diagnosis: CAD	6451	27,980	8687	6432	27,830	8365	6448	28,097	8476
Diagnosis: Cardiomyopathy	6262	26,767	7992	6493	28,533	8033	6800	29,838	8227
Diagnosis: Congenital	303	30,572	7591	312	23,355	8172	334	27,064	7291
Diagnosis: Valvular	334	24,426	8447	327	25,490	8250	339	24,837	8305
Diagnosis: Other/unknown	191	32,386	8023	199	36,955	8274	209	29,906	7770

Table Econ 26 Per person per year Medicare costs of lung transplant recipients during the year prior to transplant
Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. A, obstructive lung disease; B, pulmonary vascular disease; C, cystic fibrosis; D, restrictive lung disease; LAS, lung allocation score.

Subgroup	Patients, N	Pre-tx, 365 days	Pre-tx,90 days	Pre-tx, 30 days
All recipients	2635	32,201	10,684	3694
Age: 0-11	0	*	*	*
Age: 12-17	0	*	*	*
Age: 18-34	177	94,774	29,910	8148
Age: 35-49	240	56,319	17,548	5542
Age: 50-64	862	29,318	9594	3544
Age: ≥65	1356	21,812	7709	2882
Sex: Male	1605	29,103	10,084	3684
Sex: Female	1030	37,062	11,630	3711
Race/ethnicity: White	2265	31,543	10,383	3679
Race/ethnicity: Black	208	35,413	12,111	3406
Race/ethnicity: Hispanic	116	40,855	13,268	3946
Race/ethnicity: Asian	30	25,886	10,584	5197
Race/ethnicity: Other/unknown	16	32,157	16,363	4974
Diagnosis group: A	953	23,206	7129	2517
Diagnosis group: B	100	100,300	28,446	5224
Diagnosis group: C	202	90,872	27,112	8329
Diagnosis group: D	1380	25,132	9493	3719
Diagnosis group: Other/unknown	0	*	*	*
LAS: <30	4	*	*	*
LAS: 30-< 35	727	23,342	6534	2093
LAS: 35-< 40	587	32,293	9626	3215
LAS: 40-< 45	666	34,563	10,633	3159
LAS: 45-< 50	258	32,564	12,299	4358
LAS: 50-< 60	393	44,631	19,154	7837
LAS: ≥ 60	0	*	*	*

Table Econ 27 Total and per person per year Medicare costs of lung transplant recipients in year 1 posttransplant
Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. A, obstructive lung disease; B, pulmonary vascular disease; C, cystic fibrosis; D, restrictive lung disease; LAS, lung allocation score.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	3118	595,087,903	79,262,015	211,907	28,225
Age: 0-11	0	*	*	*	*
Age: 12-17	0	*	*	*	*
Age: 18-34	215	44,322,663	6,058,927	224,178	30,645
Age: 35-49	289	59,711,299	8,287,899	228,801	31,757
Age: 50-64	1052	189,228,658	25,421,089	198,307	26,641
Age: ≥65	1562	301,825,282	39,494,100	216,309	28,304
Sex: Male	1907	365,566,012	47,965,247	215,188	28,234
Sex: Female	1211	229,521,890	31,296,769	206,884	28,210
Race/ethnicity: White	2673	506,329,049	67,732,980	209,253	27,992
Race/ethnicity: Black	253	49,505,866	6,703,995	224,206	30,362
Race/ethnicity: Hispanic	137	28,011,726	3,434,109	239,742	29,391
Race/ethnicity: Asian	35	7,632,963	954,026	232,073	29,006
Race/ethnicity: Other/unknown	20	3,608,300	436,905	200,339	24,258
Diagnosis group: A	1162	199,076,969	27,837,515	187,133	26,167
Diagnosis group: B	119	26,874,397	3,979,904	254,803	37,735
Diagnosis group: C	237	45,902,251	6,689,963	205,106	29,893
Diagnosis group: D	1600	323,234,286	40,754,633	228,409	28,799
Diagnosis group: Other/unknown	0	*	*	*	*
LAS: <30	9	*	*	*	*
LAS: 30-< 35	880	148,020,689	20,701,592	184,239	25,767
LAS: 35-< 40	706	130,043,400	18,250,976	200,332	28,116
LAS: 40-< 45	779	149,903,161	19,885,494	214,780	28,492
LAS: 45-< 50	302	59,190,389	8,043,564	224,208	30,468
LAS: 50-< 60	442	106,415,300	12,195,432	276,075	31,639
LAS: ≥ 60	0	*	*	*	*

Table Econ 28 Total and per person per year Medicare costs of lung transplant recipients in year 2 posttransplant
Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 days posttransplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. A, obstructive lung disease; B, pulmonary vascular disease; C, cystic fibrosis; D, restrictive lung disease; LAS, lung allocation score.

Subgroup	Patients, N	Total $, Part A	Total $, Part B	PPPY $, Part A	PPPY $, Part B
All recipients	2092	76,827,552	25,135,560	39,089	12,789
Age: 0-11	0	*	*	*	*
Age: 12-17	0	*	*	*	*
Age: 18-34	148	6,428,369	1,883,054	45,816	13,421
Age: 35-49	212	7,334,532	2,772,525	36,944	13,965
Age: 50-64	726	27,037,729	8,196,791	39,278	11,908
Age: ≥65	1006	36,026,921	12,283,190	38,398	13,092
Sex: Male	1244	43,643,531	14,660,880	37,474	12,588
Sex: Female	848	33,184,021	10,474,680	41,439	13,080
Race/ethnicity: White	1815	67,087,842	22,022,088	39,270	12,891
Race/ethnicity: Black	153	4,801,203	1,668,382	34,491	11,986
Race/ethnicity: Hispanic	82	3,495,044	1,028,982	44,330	13,051
Race/ethnicity: Asian	28	931,035	291,020	35,719	11,165
Race/ethnicity: Other/unknown	14	512,427	125,089	39,542	9653
Diagnosis group: A	827	31,197,670	9,855,438	39,758	12,560
Diagnosis group: B	85	3,672,853	953,024	46,429	12,047
Diagnosis group: C	175	7,334,741	2,407,128	43,583	14,303
Diagnosis group: D	1005	34,622,289	11,919,969	37,094	12,771
Diagnosis group: Other/unknown	0	*	*	*	*
LAS: <30	7	*	*	*	*
LAS: 30-< 35	622	23,380,200	7,340,838	39,565	12,422
LAS: 35-< 40	492	18,771,602	5,875,381	40,451	12,661
LAS: 40-< 45	518	17,467,490	6,032,029	36,217	12,507
LAS: 45-< 50	196	7,395,350	2,561,448	40,421	14,000
LAS: 50-< 60	257	9,697,829	3,277,770	40,716	13,762
LAS: ≥ 60	0	*	*	*	*

Table Econ 29 Total calendar-year Medicare costs of lung transplant recipients, 2012, 2013, and 2014
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units. Values for cells with 9 or fewer recipients are suppressed. A, obstructive lung disease; B, pulmonary vascular disease; C, cystic fibrosis; D, restrictive lung disease; LAS, lung allocation score.

Subgroup	2012 Patients, N	2012 Total $, Part A	2012 Total $, Part B	2013 Patients, N	2013 Total $, Part A	2013 Total $, Part B	2014 Patients, N	2014 Total $, Part A	2014 Total $, Part B
All recipients	6590	231,318,674	53,902,003	6997	246,196,709	55,122,743	7375	249,834,897	58,514,947
Age: 0-11	8	*	*	6	*	*	6	*	*
Age: 12-17	13	383,270	74,923	12	403,326	83,621	11	648,582	105,040
Age: 18-34	578	19,727,647	4,528,712	591	23,188,288	4,830,235	598	22,493,807	5,100,337
Age: 35-49	1098	32,659,551	8,132,750	1098	29,304,492	7,531,681	1114	29,200,472	7,354,865
Age: 50-64	3349	92,936,195	23,664,455	3531	101,670,596	24,104,846	3708	104,383,854	25,957,693
Age: ≥65	1544	85,504,678	17,453,132	1759	91,582,941	18,542,438	1938	92,939,584	19,951,230
Sex: Male	3765	130,255,214	30,797,356	4029	152,975,007	33,027,120	4275	147,347,381	35,055,749
Sex: Female	2825	101,063,460	23,104,646	2968	93,221,702	22,095,623	3100	102,487,516	23,459,197
Race/ethnicity: White	5666	199,701,528	47,152,675	5958	204,728,697	47,218,118	6282	211,208,312	50,356,160
Race/ethnicity: Black	535	17,916,188	3,730,309	608	25,547,345	4,475,464	620	23,231,472	4,705,740
Race/ethnicity: Hispanic	273	8,555,909	2,055,208	316	10,689,689	2,377,815	344	10,990,793	2,519,351
Race/ethnicity: Asian	79	4,126,447	698,221	78	3,009,260	739,930	94	3,263,217	647,992
Race/ethnicity: Other/unknown	37	1,018,601	265,589	37	2,221,717	311,415	35	1,141,103	285,704
Diagnosis group: A	2624	83,446,239	21,552,041	2712	88,302,439	21,051,433	2732	79,665,708	21,102,226
Diagnosis group: B	317	9,735,870	2,355,166	321	9,280,411	2,454,488	328	8,229,392	2,246,784
Diagnosis group: C	646	19,738,004	5,289,691	651	19,821,945	5,069,484	679	25,432,435	5,786,707
Diagnosis group: D	2958	117,645,028	24,490,406	3269	127,963,155	26,365,249	3597	135,714,684	29,182,176
Diagnosis group: Other/unknown	45	753,534	214,699	44	828,761	182,089	39	792,678	197,054
LAS: <30	22	238,029	84,934	18	291,478	103,695	17	426,110	98,421
LAS: 30-< 35	1500	56,082,602	13,069,199	1657	60,108,601	13,272,070	1725	55,427,468	13,431,797
LAS: 35-< 40	1197	41,981,455	9,840,150	1283	43,319,987	10,160,870	1353	42,202,319	10,497,187
LAS: 40-< 45	1190	47,826,517	9,842,794	1320	50,364,453	10,404,103	1467	53,232,508	11,655,292
LAS: 45-< 50	453	20,409,319	4,057,683	504	20,875,943	4,348,097	574	19,570,605	4,712,034
LAS: 50-< 60	697	35,291,960	6,496,993	848	43,402,846	7,667,037	1023	53,625,040	9,629,057
LAS: ≥ 60	1531	29,488,793	10,510,250	1367	27,833,400	9,166,871	1216	25,350,847	8,491,159

Table Econ 30 Per person per year calendar-year Medicare costs of lung transplant recipients, 2012, 2013, and 2014
Costs paid by Medicare in each calendar year for recipients alive with graft function in the given year, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Per person per year costs are given in $ units. Values for cells with 9 or fewer recipients are suppressed. A, obstructive lung disease; B, pulmonary vascular disease; C, cystic fibrosis; D, restrictive lung disease; LAS, lung allocation score.

Subgroup	2012 Patients, N	2012 PPPY $, Part A	2012 PPPY $, Part B	2013 Patients, N	2013 PPPY $, Part A	2013 PPPY $, Part B	2014 Patients, N	2014 PPPY $, Part A	2014 PPPY $, Part B
All recipients	6590	40,042	9331	6997	40,387	9043	7375	38,579	9036
Age: 0-11	8	*	*	6	*	*	6	*	*
Age: 12-17	13	31,275	6114	12	38,148	7909	11	59,451	9628
Age: 18-34	578	38,157	8759	591	43,707	9104	598	41,763	9470
Age: 35-49	1098	32,662	8133	1098	29,216	7509	1114	28,470	7171
Age: 50-64	3349	30,909	7870	3531	32,305	7659	3708	31,536	7842
Age: ≥65	1544	69,302	14,146	1759	65,483	13,258	1938	58,645	12,589
Sex: Male	3765	39,712	9389	4029	44,034	9507	4275	39,632	9429
Sex: Female	2825	40,475	9253	2968	35,555	8427	3100	37,159	8506
Race/ethnicity: White	5666	40,230	9499	5958	39,468	9103	6282	38,387	9152
Race/ethnicity: Black	535	37,911	7893	608	48,006	8410	620	41,778	8463
Race/ethnicity: Hispanic	273	35,442	8514	316	39,012	8678	344	36,592	8388
Race/ethnicity: Asian	79	62,998	10,660	78	42,664	10,490	94	38,287	7603
Race/ethnicity: Other/unknown	37	30,427	7934	37	69,292	9713	35	35,474	8882
Diagnosis group: A	2624	35,746	9232	2712	37,130	8852	2732	32,823	8694
Diagnosis group: B	317	33,848	8188	321	32,020	8469	328	27,273	7446
Diagnosis group: C	646	33,837	9068	651	33,509	8570	679	41,327	9403
Diagnosis group: D	2958	46,522	9685	3269	45,821	9441	3597	43,837	9426
Diagnosis group: Other/unknown	45	17,631	5023	44	18,957	4165	39	22,169	5511
LAS: <30	22	12,786	4562	18	17,050	6065	17	28,449	6571
LAS: 30-< 35	1500	42,772	9967	1657	42,033	9281	1725	36,304	8798
LAS: 35-< 40	1197	40,615	9520	1283	38,937	9133	1353	35,700	8880
LAS: 40-< 45	1190	46,731	9617	1320	44,101	9110	1467	41,758	9143
LAS: 45-< 50	453	55,053	10,945	504	48,710	10,145	574	40,578	9770
LAS: 50-< 60	697	59,715	10,993	848	62,302	11,006	1023	61,609	11,063
LAS: ≥ 60	1531	20,646	7359	1367	21,933	7224	1216	22,542	7550